SANDUPHQPharmaceuticals
Sandu Pharmaceuticals, Inc — PE Ratio & Valuation Analysis
₹30.52
-6.58%
Current P/E23.53xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E37.9x37.9% below avg
✅
25.9% Discount to Industry
SANDUPHQ P/E 23.53x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹1.51 | ₹57 | 37.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Sandu Pharmaceuticals, Inc Valuation
Sandu Pharmaceuticals, Inc (SANDUPHQ) currently trades at 23.53x earnings. The Pharmaceuticals sector average PE is 31.77x. SANDUPHQ is trading at a discount to peers — may indicate relative value. Historically, SANDUPHQ has traded at an average PE of 37.9x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
3.75%
Dividend Yield
2.02%
More on Sandu Pharmaceuticals, Inc
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.